1993
DOI: 10.1016/0014-5793(93)81108-c
|View full text |Cite
|
Sign up to set email alerts
|

Monoclonal anti‐biotin antibodies simulate avidin m the recognition of biotin

Abstract: The sequence of the Vu gene of a monoclonal anti-biotin antibody was determined. Biotin-binding motifs, similar to those in avidin and streptavidin, were identified in complementarity determining regions 2 and 3, suggesting that natural selection of functional motifs may occur in unrelated protein types.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
38
0

Year Published

2002
2002
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(39 citation statements)
references
References 18 publications
(9 reference statements)
1
38
0
Order By: Relevance
“…Recombinant chimeric IgG2 and IgG3 antibodies (against biotin) were produced essentially as described before (21) by cloning synthetic constructs coding for the variable domains (22, 23) and IgG2, IgG3, and κ constant domains (obtained from GeneArt; Invitrogen) into a pcDNA3.1 expression vector (Invitrogen). Other monoclonal IgG1, IgG2, and IgG4 antibodies used were adalimumab (Humira, Abbott), panitumumab (Vectibix, Amgen), and natalizumab (Tysabri, Biogen Idec, Inc.).…”
Section: Methodsmentioning
confidence: 99%
“…Recombinant chimeric IgG2 and IgG3 antibodies (against biotin) were produced essentially as described before (21) by cloning synthetic constructs coding for the variable domains (22, 23) and IgG2, IgG3, and κ constant domains (obtained from GeneArt; Invitrogen) into a pcDNA3.1 expression vector (Invitrogen). Other monoclonal IgG1, IgG2, and IgG4 antibodies used were adalimumab (Humira, Abbott), panitumumab (Vectibix, Amgen), and natalizumab (Tysabri, Biogen Idec, Inc.).…”
Section: Methodsmentioning
confidence: 99%
“…Recombinant chimeric IgG1, IgG2, IgG3, and IgG4 antibodies, all specific for biotin, were produced as described previously by cloning synthetic constructs coding for the variable domains and IgG1, IgG2, IgG3, and IgG4 and κ constant domains (GeneArt; Invitrogen) into a pcDNA3.1 expression vector (Invitrogen). Recombinant chimeric IgG1 and IgG4 antibodies (against cat antigen Fel d1 and birch pollen antigen Bet v1) and mutants (IgG1‐C H 3[IgG4], IgG1‐R355Q, IgG1‐K409R, IgG1‐Q419E, IgG1‐P445L) used for pinpointing specific anti‐IgG4–negative RF reactivity were produced as described previously .…”
Section: Methodsmentioning
confidence: 99%
“…1B. 38 There are 83 lysine groups per IgG, available for covalent immobilization onto activated NHS ester termini of SAMs.…”
Section: Resultsmentioning
confidence: 99%
“…The typical dimensions of IgG are approximately 4.0 nm × 8.5 nm × 14.5 nm. 38 There are 83 lysine groups per IgG.…”
Section: Methodsmentioning
confidence: 99%